Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06550596
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-05
Brief Title:
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomized Controlled Multicenter Clinical Trial Evaluating Dehydrated Human Amnion Membrane dhAM and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy of dehydrated human amnion membrane dhAM and standard of care SOC versus SOC alone in the closure of nonhealing diabetic foot ulcers DFUs
Detailed Description:
AXOCAMP is a multi-center randomized controlled clinical trial The study will evaluate the efficacy of dehydrated human amnion membrane dhAM and standard of care SOC versus SOC alone in the closure of nonhealing diabetic foot ulcers DFUs
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None